Cargando…

A multi‐center, randomized, open‐label, parallel group study of a natural micronized progesterone vaginal tablet as a luteal support agent in Japanese women undergoing assisted reproductive technology

PURPOSE: To verify sufficient progesterone supplementation during the luteal phase and to determine the efficacy and safety of a natural micronized progesterone vaginal tablet (FE 999913) in Japanese women undergoing in vitro fertilization‐embryo transfer or intracytoplasmic sperm injection. METHODS...

Descripción completa

Detalles Bibliográficos
Autor principal:	Fujiwara, Toshihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Japan 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592497/ https://www.ncbi.nlm.nih.gov/pubmed/26457065 http://dx.doi.org/10.1007/s12522-015-0211-y

Ejemplares similares

A randomised control trial on oral dydrogesterone versus micronized vaginal progesterone pessary for luteal phase support in in vitro fertilization cycles
por: Ikechebelu, Joseph Ifeanyichukwu, et al.
Publicado: (2023)

Luteal Phase Support in assisted reproductive technology treatment: focus on Endometrin® (progesterone) vaginal insert
por: Check, Jerome H
Publicado: (2009)

A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization
por: Tournaye, Herman, et al.
Publicado: (2017)

Oral versus Vaginal Micronized Progesterone for the Treatment of Threatened Miscarriage
por: Parveen, Rashida, et al.
Publicado: (2021)

Comparison of Subcutaneous and Vaginal Progesterone Used for Luteal Phase Support in Patients Undergoing Intracytoplasmic Sperm Injection Cycles
por: Salehpour, Saghar, et al.
Publicado: (2021)

Vaginal micronized progesterone capsule versus vaginal progesterone gel for lutheal support in normoresponder IVF/ICSI-ET cycles
por: Sofuoglu, Kenan, et al.
Publicado: (2015)

Phase III trial of 8% vaginal progesterone gel for luteal phase support in Japanese women undergoing in vitro fertilization and fresh embryo transfer cycles
por: Kokeguchi, Shoji, et al.
Publicado: (2016)

Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial
por: Griesinger, Georg, et al.
Publicado: (2018)

Patients’ administration preferences: progesterone vaginal insert (Endometrin®) compared to intramuscular progesterone for Luteal phase support
por: Beltsos, Angeline N, et al.
Publicado: (2014)

Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence
por: Coomarasamy, Arri, et al.
Publicado: (2020)

Subcutaneous progesterone versus vaginal progesterone for luteal-phase support in frozen-thawed embryo transfer: A cross-sectional study
por: Aflatoonian, Abbas, et al.
Publicado: (2021)

Pharmacokinetics of hard micronized progesterone capsules via vaginal or oral route compared with soft micronized capsules in healthy postmenopausal women: a randomized open-label clinical study
por: Wang, Hanbi, et al.
Publicado: (2019)

Supplementary dydrogesterone is beneficial as luteal phase support in artificial frozen-thawed embryo transfer cycles compared to micronized progesterone alone
por: Vidal, Angela, et al.
Publicado: (2023)

Efficacy, safety and tolerability of progesterone vaginal pessaries versus progesterone vaginal gel for luteal phase support after in vitro fertilisation: a randomised controlled trial
por: Saunders, Helen, et al.
Publicado: (2020)

Do early luteal serum progesterone levels predict the reproductive outcomes in IVF with oral dydrogesterone for luteal phase support?
por: Netter, Antoine, et al.
Publicado: (2019)

Co-administration of GnRH agonists with vaginal progesterone compared to vaginal progesterone in luteal phase support of the frozen-thawed embryo transfer cycle: An RCT
por: Zareii, Afsoon, et al.
Publicado: (2021)

Progesterone Hypersensitivity: A Challenge for Luteal Support
por: Gupta, Astha, et al.
Publicado: (2018)

Clinical Re-evaluation on Bioequivalence and Relative Bioavailability of Micronized Progesterone Hard Capsule (Yimaxin) and Micronized Progesterone Soft Capsule (Utrogestan) under Vaginal and Oral Administration Routes
por: Wang, Hanbi, et al.
Publicado: (2021)

Progesterone signaling in the regulation of luteal steroidogenesis
por: Yakin, Kayhan, et al.
Publicado: (2023)

Progesterone for Luteal Phase Support in In Vitro Fertilization: Comparison of Vaginal and Rectal Pessaries to Vaginal Capsules: A Randomized Controlled Study
por: Khrouf, Mohamed, et al.
Publicado: (2017)

Progesterone administration for luteal phase deficiency in human reproduction: an old or new issue?
por: Palomba, Stefano, et al.
Publicado: (2015)

A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization
por: Baker, Valerie L., et al.
Publicado: (2014)

Subcutaneous progesterone versus vaginal progesterone for luteal phase support in in vitro fertilization: A retrospective analysis from daily clinical practice
por: Schütt, Marcel, et al.
Publicado: (2021)

A questionnaire-based audit to assess overall experience and convenience among patients using vaginal progesterone tablets (Lutigest(®)) for luteal phase support during IVF treatment
por: Heine, Polly, et al.
Publicado: (2017)

Luteal phase bleeding after IVF cycles: comparison between progesterone vaginal gel and intramuscular progesterone and correlation with pregnancy outcomes
por: Jabara, Sami, et al.
Publicado: (2009)

Oral dydrogesterone vs. vaginal progesterone capsules for luteal-phase support in women undergoing embryo transfer: a systematic review and meta-analysis
por: Barbosa, Marina Wanderley Paes, et al.
Publicado: (2018)

A Comparison of Oral Dydrogesterone with Vaginal Progesterone for Luteal-Phase Support in In vitro Fertilization: A Randomized Controlled Trial
por: Naghshineh, Elham, et al.
Publicado: (2023)

Luteal Phase Support in Intrauterine Insemination Cycles: A Randomized Clinical Trial of Vaginal Versus Intramuscular Progesterone Administration
por: Azargoon, Azam, et al.
Publicado: (2022)

Addition of intramuscular to vaginal progesterone for luteal phase support in fresh embryo transfer cycles: A cross-sectional study
por: Jalaliani, Samaneh, et al.
Publicado: (2022)

Vaginal progesterone as luteal phase support in natural cycle frozen-thawed embryo transfer (ProFET): protocol for a multicentre, open-label, randomised controlled trial
por: Stadelmann, Caroline, et al.
Publicado: (2022)

The addition of dydrogesterone improves the outcomes of pregnant women with low progesterone levels when receiving vaginal progesterone alone as luteal support in HRT‐FET cycles
por: Toriumi, Rena, et al.
Publicado: (2023)

Influence of the Efavirenz Micronization on Tableting and Dissolution
por: Pinto, Eduardo Costa, et al.
Publicado: (2012)

Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in in vitro fertilization (IVF): A randomized clinical trial
por: Salehpour, Saghar, et al.
Publicado: (2013)

Effect of luteal phase support with vaginal progesterone on pregnancy outcomes in natural frozen embryo transfer cycles: A meta-analysis
por: Seol, Aeran, et al.
Publicado: (2020)

Efficacy of four vaginal progesterones for luteal phase support in frozen‐thawed embryo transfer cycles: A randomized clinical trial
por: Shiba, Reiko, et al.
Publicado: (2019)

Adding Weekly Intramuscular Progesterone to a Twice Daily Vaginal Progesterone Capsule for Luteal Phase Support in IVF/ICSI Cycles Results in Similar Live Birth Rates
por: Gari, Salwa, et al.
Publicado: (2022)

Intramuscular progesterone (Gestone) versus vaginal progesterone suppository (Cyclogest) for luteal phase support in cycles of in vitro fertilization–embryo transfer: patient preference and drug efficacy
por: Zaman, Amal Yaseen, et al.
Publicado: (2017)

Daytime Variation in Serum Progesterone During the Mid-Luteal Phase in Women Undergoing In Vitro Fertilization Treatment
por: Thomsen, Lise Haaber, et al.
Publicado: (2018)

Luteal Phase Support Using Subcutaneous Progesterone: A Systematic Review
por: Conforti, Alessandro, et al.
Publicado: (2021)

Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysis
por: Griesinger, Georg, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2lb15jpn2lsa8pungmek2ar26f